The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation.
Tavor S, Eisenbach M, Jacob-Hirsch J, Golan T, Petit I, Benzion K, Kay S, Baron S, Amariglio N, Deutsch V, Naparstek E, Rechavi G.
Tavor S, et al. Among authors: deutsch v.
Leukemia. 2008 Dec;22(12):2151-5158. doi: 10.1038/leu.2008.238. Epub 2008 Sep 4.
Leukemia. 2008.
PMID: 18769446